-
1
-
-
15244348050
-
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
-
Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073–1086
-
(2005)
Lancet
, vol.365
, pp. 1073-1086
-
-
Tarr, P.I.1
Gordon, C.A.2
Chandler, W.L.3
-
2
-
-
33645557561
-
Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome
-
Zimmerhackl LB, Besbas N, Jungraithmayr T et al. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost 2006; 32: 113–120
-
(2006)
Semin Thromb Hemost
, vol.32
, pp. 113-120
-
-
Zimmerhackl, L.B.1
Besbas, N.2
Jungraithmayr, T.3
-
3
-
-
84947260202
-
An international consensus approach to the management of atypical hemolytic uremic syndrome in children
-
Loirat C, Fakhouri F, Ariceta G et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pe-diatr Nephrol 2016; 31: 15–39
-
(2016)
Pe-Diatr Nephrol
, vol.31
, pp. 15-39
-
-
Loirat, C.1
Fakhouri, F.2
Ariceta, G.3
-
4
-
-
0017595341
-
Breakdown products of C3 and factor B in hemolytic-uremic syndrome
-
Kim Y, Miller K, Michael AF. Breakdown products of C3 and factor B in hemolytic-uremic syndrome. J Lab Clin Med 1977; 89: 845–850
-
(1977)
J Lab Clin Med
, vol.89
, pp. 845-850
-
-
Kim, Y.1
Miller, K.2
Michael, A.F.3
-
5
-
-
0018851755
-
The complement system in hemolytic-uremic syndrome in childhood
-
Monnens L, Molenaar J, Lambert PH et al. The complement system in hemolytic-uremic syndrome in childhood. Clin Nephrol 1980; 13: 168–171
-
(1980)
Clin Nephrol
, vol.13
, pp. 168-171
-
-
Monnens, L.1
Molenaar, J.2
Lambert, P.H.3
-
6
-
-
73649122762
-
Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome
-
Thurman JM, Marians R, Emlen W et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 4: 1920–1924
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 1920-1924
-
-
Thurman, J.M.1
Marians, R.2
Emlen, W.3
-
7
-
-
84924358744
-
Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome
-
Arvidsson I, Stahl AL, Hedstrom MM et al. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome. J Immunol 2015; 194: 2309–2318
-
(2015)
J Immunol
, vol.194
, pp. 2309-2318
-
-
Arvidsson, I.1
Stahl, A.L.2
Hedstrom, M.M.3
-
8
-
-
84930415185
-
Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome
-
Ferraris JR, Ferraris V, Acquier AB et al. Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome. Clin Exp Immunol 2015; 181: 118–125
-
(2015)
Clin Exp Immunol
, vol.181
, pp. 118-125
-
-
Ferraris, J.R.1
Ferraris, V.2
Acquier, A.B.3
-
9
-
-
80155167232
-
Inhibition of terminal complement activation in severe Shiga toxin-associated HUS - Perfect example for a fast track from bench to bedside
-
Orth-Holler D, Riedl M, Wurzner R. Inhibition of terminal complement activation in severe Shiga toxin-associated HUS - perfect example for a fast track from bench to bedside. EMBO Mol Med 2011; 3: 617–619
-
(2011)
EMBO Mol Med
, vol.3
, pp. 617-619
-
-
Orth-Holler, D.1
Riedl, M.2
Wurzner, R.3
-
10
-
-
84902294881
-
Role of complement in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome
-
Orth-Holler D, Wurzner R. Role of complement in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Semin Thromb Hemost 2014; 40: 503–507
-
(2014)
Semin Thromb Hemost
, vol.40
, pp. 503-507
-
-
Orth-Holler, D.1
Wurzner, R.2
-
12
-
-
84941369290
-
Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement
-
Pape L, Hartmann H, Bange FC et al. Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore) 2015; 94: e1000
-
(2015)
Medicine (Baltimore)
, vol.94
-
-
Pape, L.1
Hartmann, H.2
Bange, F.C.3
-
13
-
-
84868562798
-
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. Coli O104:H4 induced haemolytic-uraemic syndrome: An analysis of the German STEC-HUS registry
-
Kielstein JT, Beutel G, Fleig S et al. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 2012; 27: 3807–3815
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 3807-3815
-
-
Kielstein, J.T.1
Beutel, G.2
Fleig, S.3
-
14
-
-
84865491675
-
An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: Presentation and short-term outcome in children
-
Loos S, Ahlenstiel T, Kranz B et al. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 2012; 55: 753–759
-
(2012)
Clin Infect Dis
, vol.55
, pp. 753-759
-
-
Loos, S.1
Ahlenstiel, T.2
Kranz, B.3
-
15
-
-
0002630748
-
Complement and complement fixation
-
Kabat E, Mayer MM (eds.) Springfield, IL: CC Thomas
-
Mayer MM. Complement and complement fixation. In: Kabat E, Mayer MM (eds). Experimental Immunochemistry. Springfield, IL: CC Thomas, 1961, 133–240
-
(1961)
Experimental Immunochemistry
, pp. 133-240
-
-
Mayer, M.M.1
-
16
-
-
0020682488
-
A study of optimal reaction conditions for an assay of the human alternative complement pathway
-
Joiner KA, Hawiger A, Gelfand JA. A study of optimal reaction conditions for an assay of the human alternative complement pathway. Am J Clin Pathol 1983; 79: 65–72
-
(1983)
Am J Clin Pathol
, vol.79
, pp. 65-72
-
-
Joiner, K.A.1
Hawiger, A.2
Gelfand, J.A.3
-
17
-
-
0021197082
-
Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d
-
Brandslund I, Teisner B, Hyltoft Petersen P et al. Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d. Scand J Clin Lab Invest Suppl 1984; 168: 57–73
-
(1984)
Scand J Clin Lab Invest Suppl
, vol.168
, pp. 57-73
-
-
Brandslund, I.1
Teisner, B.2
Hyltoft Petersen, P.3
-
18
-
-
0031458902
-
Molecular, genetic, and functional analysis of homozygous C8 beta-chain deficiency in two siblings
-
Kotnik V, Luznik-Bufon T, Schneider PM et al. Molecular, genetic, and functional analysis of homozygous C8 beta-chain deficiency in two siblings. Immunopharmacology 1997; 38: 215–221
-
(1997)
Immunopharmacology
, vol.38
, pp. 215-221
-
-
Kotnik, V.1
Luznik-Bufon, T.2
Schneider, P.M.3
-
19
-
-
0031445962
-
Complement factor I deficiency in a family with recurrent infections
-
Leitao MF, Vilela MM, Rutz R et al. Complement factor I deficiency in a family with recurrent infections. Immunopharmacology 1997; 38: 207–213
-
(1997)
Immunopharmacology
, vol.38
, pp. 207-213
-
-
Leitao, M.F.1
Vilela, M.M.2
Rutz, R.3
-
20
-
-
84893164403
-
Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: The example of retinal dystrophies
-
Eisenberger T, Neuhaus C, Khan AO et al. Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One 2013; 8: e78496
-
(2013)
PLoS One
, vol.8
-
-
Eisenberger, T.1
Neuhaus, C.2
Khan, A.O.3
-
21
-
-
84922353943
-
An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease
-
Eisenberger T, Decker C, Hiersche M et al. An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease. PLoS One 2015; 10: e0116680
-
(2015)
PLoS One
, vol.10
-
-
Eisenberger, T.1
Decker, C.2
Hiersche, M.3
-
22
-
-
84881028445
-
ANKS6 is a central component of a ne-phronophthisis module linking NEK8 to INVS and NPHP3
-
Hoff S, Halbritter J, Epting D et al. ANKS6 is a central component of a ne-phronophthisis module linking NEK8 to INVS and NPHP3. Nat Genet 2013; 45: 951–956
-
(2013)
Nat Genet
, vol.45
, pp. 951-956
-
-
Hoff, S.1
Halbritter, J.2
Epting, D.3
-
23
-
-
84876338226
-
Combined NGS approaches identify mutations in the intraflagellar transport gene IFT140 in skeletal ciliopathies with early progressive kidney Disease
-
Schmidts M, Frank V, Eisenberger T et al. Combined NGS approaches identify mutations in the intraflagellar transport gene IFT140 in skeletal ciliopathies with early progressive kidney Disease. Hum Mutat 2013; 34: 714–724
-
(2013)
Hum Mutat
, vol.34
, pp. 714-724
-
-
Schmidts, M.1
Frank, V.2
Eisenberger, T.3
-
24
-
-
38349172121
-
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
-
Fang CJ, Fremeaux-Bacchi V, Liszewski MK et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 2008; 111: 624–632
-
(2008)
Blood
, vol.111
, pp. 624-632
-
-
Fang, C.J.1
Fremeaux-Bacchi, V.2
Liszewski, M.K.3
-
25
-
-
78449293078
-
Genetics and complement in atypical HUS
-
Kavanagh D, Goodship T. Genetics and complement in atypical HUS. Pe-diatr Nephrol 2010; 25: 2431–2442
-
(2010)
Pe-Diatr Nephrol
, vol.25
, pp. 2431-2442
-
-
Kavanagh, D.1
Goodship, T.2
-
26
-
-
84874610717
-
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype
-
Bresin E, Rurali E, Caprioli J et al. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol 2013; 24: 475–486
-
(2013)
J Am Soc Nephrol
, vol.24
, pp. 475-486
-
-
Bresin, E.1
Rurali, E.2
Caprioli, J.3
-
27
-
-
84936802263
-
Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels
-
Kavanagh D, Yu Y, Schramm EC et al. Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels. Hum Mol Genet 2015; 24: 3861–3870
-
(2015)
Hum Mol Genet
, vol.24
, pp. 3861-3870
-
-
Kavanagh, D.1
Yu, Y.2
Schramm, E.C.3
-
28
-
-
84891753035
-
Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome
-
Bu F, Maga T, Meyer NC et al. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2014; 25: 55–64
-
(2014)
J Am Soc Nephrol
, vol.25
, pp. 55-64
-
-
Bu, F.1
Maga, T.2
Meyer, N.C.3
-
29
-
-
0026666338
-
Hypocomplementemia and leuko-cytosis in diarrhea-associated hemolytic uremic syndrome
-
Robson WL, Leung AK, Fick GH et al. Hypocomplementemia and leuko-cytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 1992; 62: 296–299
-
(1992)
Nephron
, vol.62
, pp. 296-299
-
-
Robson, W.L.1
Leung, A.K.2
Fick, G.H.3
-
30
-
-
70350693665
-
Shiga toxin activates complement and binds factor H: Evidence for an active role of complement in hemolytic uremic syndrome
-
Orth D, Khan AB, Naim A et al. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 2009; 182: 6394–6400
-
(2009)
J Immunol
, vol.182
, pp. 6394-6400
-
-
Orth, D.1
Khan, A.B.2
Naim, A.3
-
31
-
-
84880082112
-
Shiga toxin-producing Escherichia coli: Factors involved in virulence and cattle colonization
-
Etcheverría AI, Padola NL. Shiga toxin-producing Escherichia coli: factors involved in virulence and cattle colonization. Virulence 2013; 4: 366–372
-
(2013)
Virulence
, vol.4
, pp. 366-372
-
-
Etcheverría, A.I.1
Padola, N.L.2
-
32
-
-
0035067379
-
Intrarenal synthesis of complement
-
Zhou W, Marsh JE, Sacks SH. Intrarenal synthesis of complement. Kidney Int 2001; 59: 1227–1235
-
(2001)
Kidney Int
, vol.59
, pp. 1227-1235
-
-
Zhou, W.1
Marsh, J.E.2
Sacks, S.H.3
-
33
-
-
84902134692
-
Spectrum of complement-mediated thrombotic microangiopathies: Pathogenetic insights identifying novel treatment approaches
-
Riedl M, Fakhouri F, Le Quintrec M et al. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 2014; 40: 444–464
-
(2014)
Semin Thromb Hemost
, vol.40
, pp. 444-464
-
-
Riedl, M.1
Fakhouri, F.2
Le Quintrec, M.3
|